About 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide
5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide (PubChem CID 67077482) has the molecular formula C11H17N5O3
and a molecular weight of 267.29 g/mol. Its IUPAC name is 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide.
Analyze 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide?
The IUPAC name of 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide (CID 67077482) is 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide.
What is the SMILES notation for 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide?
The canonical SMILES for 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide is Cc1nc(C(=O)N[C@H]2CCCNC2)c(NC(N)=O)o1.
What is the InChIKey of 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide?
The InChIKey is DBYUDINEBGVYEV-ZETCQYMHSA-N. The full InChI is InChI=1S/C11H17N5O3/c1-6-14-8(10(19-6)16-11(12)18)9(17)15-7-3-2-4-13-5-7/h7,13H,2-5H2,1H3,(H,15,17)(H3,12,16,18)/t7-/m0/s1.
What are the key properties of 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide?
5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide has a molecular weight of 267.29 g/mol, XLogP of -0.04, 3 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-(carbamoylamino)-2-methyl-N-[(3S)-piperidin-3-yl]-1,3-oxazole-4-carboxamide is sourced from PubChem (CID 67077482), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).